skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

About Avery Levine

California, USA

+8 year(s) experience

Avery_Levine_Pharma_Intelligence
As an Analyst, Avery Levine covers genitourinary and infectious diseases, including vaccines. She provides research support for clients, develops search strategies and offers industry analysis.

Analyst Articles

Articles by Avery Levine

  • Citeline

    Horizons in HIV Drug Development – What’s Past is Prologue

    By Avery Levine 10 Apr 2019

    While AIDS therapy was once confined to palliative care, clinical progress in the wake of the landmark 1987 approval of zidovudine has seen HIV demoted to a chronic but manageable infection. Following the initial fledgling steps and missteps, the mid-1990s saw the introduction of the now-familiar three-drug combination regimens that raised expectations for a pharmaceutical solution to the epidemic.

    Topic Infectious diseases

  • Trialtrove

    Sepsis and the Receding Grail

    By Avery Levine 05 Jan 2018

    Sepsis is a life-threatening illness culminating in multi-organ dysfunction paired with a systemic inflammatory response. The disease burden is considerable: it is the single most expensive condition treated in hospitals, with annual costs in the US projected at nearly $24bn.

  • Trialtrove

    CMV, The Neglected Child

    By Avery Levine 09 Nov 2016

    As Zika-related brain abnormalities resulting from congenital infection continue to claim center stage, there has been less fanfare drawn to other viral infections competing for resources in pharmaceutical development.

    Topic Clinical trials blog